Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

Reiss, KA; Mick, R; Teitelbaum, U; O'Hara, M; Schneider, C; Massa, R; Karasic, T; Tondon, R; Onyiah, C; Gosselin, MK; Donze, A; Domchek, SM; Vonderheide, RH

Reiss, KA (通讯作者),Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Pennsylvania, PA 19106 USA.

LANCET ONCOLOGY, 2022; 23 (8): 1009

Abstract

Background Establishing alternatives to lifelong chemotherapy for patients with advanced pancreatic cancer has been proposed to address chemotherapy r......

Full Text Link